コンテンツへスキップ
Merck
  • Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.

Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.

Cell reports (2020-09-24)
Sara C Buch-Larsen, Ivo A Hendriks, Jean M Lodge, Martin Rykær, Benjamin Furtwängler, Evgenia Shishkova, Michael S Westphall, Joshua J Coon, Michael L Nielsen
要旨

ADP-ribosylation (ADPr) is a post-translational modification that plays pivotal roles in a wide range of cellular processes. Mass spectrometry (MS)-based analysis of ADPr under physiological conditions, without relying on genetic or chemical perturbation, has been hindered by technical limitations. Here, we describe the applicability of activated ion electron transfer dissociation (AI-ETD) for MS-based proteomics analysis of physiological ADPr using our unbiased Af1521 enrichment strategy. To benchmark AI-ETD, we profile 9,000 ADPr peptides mapping to >5,000 unique ADPr sites from a limited number of cells exposed to oxidative stress and identify 120% and 28% more ADPr peptides compared to contemporary strategies using ETD and electron-transfer higher-energy collisional dissociation (EThcD), respectively. Under physiological conditions, AI-ETD identifies 450 ADPr sites on low-abundant proteins, including in vivo cysteine modifications on poly(ADP-ribosyl)polymerase (PARP) 8 and tyrosine modifications on PARP14, hinting at specialist enzymatic functions for these enzymes. Collectively, our data provide insights into the physiological regulation of ADPr.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
トリプシン ブタ膵臓由来, Proteomics Grade, BioReagent, Dimethylated
Sigma-Aldrich
PARG human, recombinant, expressed in Sf21 cells, His tagged, >95% (SDS-PAGE)